Q
QuantAbundance

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

31,229 signal articles · 0 in last 24h · 160,153 total before filter · latest 1d ago
0last 24h
609last 7d
87● bullish (7d)
65● bearish (7d)
214publishers
AllMacro116Earnings166M&A62Regulatory12Product10Analyst17
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings?
StockStory112d agoneutral
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, CVS Health has been a great trade, beating the S&P 500 by 20%. Its stock price has climbed to $100.39, representing a healthy 26.4% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Occidental Petroleum (OXY): Buy, Sell, or Hold Post Q1 Earnings?
StockStory112d agoneutral
Occidental Petroleum (OXY): Buy, Sell, or Hold Post Q1 Earnings?

Occidental Petroleum’s 35% return over the past six months has outpaced the S&P 500 by 28.6%, and its stock price has climbed to $55.44 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

How To Earn $500 A Month From Jabil Stock Ahead Of Q3 Earnings
Benzinga112d agoneutral
How To Earn $500 A Month From Jabil Stock Ahead Of Q3 Earnings

Jabil Inc.will release earnings for its third quarter before the opening bell on Wednesday, June 17. Analysts expect the Florida-based manufacturer to report quarterly earnings of $3.10 per share. That’s up from $2.55 per share in the year-ago period. The...

Adobe Beats Expectations and Raises Outlook, but Shares Fall on ARR Concerns (ADBE)
InvestorsHub113d agobullish
Adobe Beats Expectations and Raises Outlook, but Shares Fall on ARR Concerns (ADBE)

Adobe (NASDAQ:ADBE) delivered stronger-than-expected second-quarter results on Thursday, surpassing Wall Street forecasts for both revenue and earnings while increasing its full-year guidance. However, the stock moved lower in premarket trading after investors focused on unchanged annual recurring revenue projections and another senior leadership transition.

Oscar Health (OSCR) Stock Valuation After Conference Rally And Reaffirmed 2026 Guidance
Simply Wall St.113d agobullish
Oscar Health (OSCR) Stock Valuation After Conference Rally And Reaffirmed 2026 Guidance

Oscar Health (OSCR) has been back on investors’ radar after a sharp stock rally following its business update at the Goldman Sachs Healthcare Conference, where management reaffirmed full-year 2026 guidance and highlighted favorable utilization trends. See our latest analysis for Oscar Health. The stock’s rally around the Goldman Sachs Healthcare Conference and upbeat commentary on utilization trends come on top of very strong momentum, with a 90 day share price return of 118.52% and a 1 year...

Adobe Q2 Earnings Call Highlights
MarketBeat113d agoneutral
Adobe Q2 Earnings Call Highlights

Adobe (NASDAQ:ADBE) reported record fiscal second-quarter revenue and raised its full-year revenue outlook, while executives outlined a strategic shift toward more aggressive freemium user acquisition across Acrobat, Express and Firefly that is expected to weigh on second-half annual recurring reven